📋 RUBIUS THERAPEUTICS, INC. (RUBY) - Executive Changes
Filing Date: 2022-10-17
Accepted: 2022-10-17 16:05:19
Event Type: Executive Changes
Event Details:
Rubius Therapeutics (company was delisted NASDAQ) (RUBY) Announces Executive and Board Changes
Rubius Therapeutics (company was delisted NASDAQ) (RUBY) announced changes to its leadership team and board of directors.
David Epstein was departed. The position includes: any committee. The change is effective as of October 17, 2022.
Executive Changes Details:
Personnel Involved: David Epstein
Actions: Departed
Committee Assignments: any committee
👥 Executive & Board Changes:
Personnel Involved: David Epstein
Actions: Departed
Committee Assignments: any committee
Effective Dates: October 17, 2022
💼 Business Developments:
Partnership
Acquisition: Not available
Licensing: Not available
Regulatory Approval: Not available
Executive Changes
Structured Data:
Company Name: Rubius Therapeutics (company was delisted NASDAQ)
📋 RUBIUS THERAPEUTICS, INC. (RUBY) - Executive Changes
Filing Date: 2022-10-17
Accepted: 2022-10-17 16:05:19
Event Type: Executive Changes
Event Details:
👥 Executive & Board Changes:
💼 Business Developments:
Structured Data: